DrugSupplement
Copper clinical trials
- studies test it
- 10
- open now
- 1
- in phase 3
- 1
- first study started
- 2004
Keep track of what changes. Save the Copper studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2011 (3); 1 more planned to start later
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
- Phase 3
- 1
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 9
Insel Gruppe AG, University Hospital Bern (1) · Cantex Pharmaceuticals (1) · Queen's University, Belfast (1) · Affordance (1) · University Hospital, Bordeaux (1) · Phoenix Neurological Associates, LTD (1) · University Hospital, Saarland (1) · Olympion Medical Center (1)
Often tested with
Tested in the same studies.
Zinc (5) · Lutein (4) · Zeaxanthins (4) · Fish Oils (4) · Ascorbic Acid (4) · Alpha-Tocopherol (4) · Cholecalciferol (4) · Selenium (4)
Studies
Open first, then newest update. How each study uses Copper is read from its arms, and is right about nine times in ten.
Testing it · 10
- Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma MultiformNot yet recruitingPhase 2Olympion Medical CenterNCT01777919Written as Copper
- Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.WithdrawnPhase 2National Cancer Institute, SlovakiaNCT04265274Written as Copper
- FLIO and the Influence of Oral Lutein Supplementation on Macular PigmentCompletedPhase 4Insel Gruppe AG, University Hospital BernNCT04761341Written as NUTROF TOTAL
- A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate CancerTerminatedPhase 1Daniel George, MDNCT02963051Written as Copper
- Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent GlioblastomaCompletedPhase 2Cantex PharmaceuticalsNCT03034135Written as Disulfiram/Copper
- Investigation of the Genetic and Environmental Determinants of MP Including Response to SupplementationCompletedNot applicableQueen's University, BelfastNCT01778231Written as Nutrof Total
- Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine SupplementationCompletedNot applicableAffordanceNCT01404845Written as Nutrof Total
- Lutein Influence on Macula of Persons Issued From Amd ParentsCompletedPhase 3University Hospital, BordeauxNCT01269697Written as Nutrof Total
- Safety Study of High Doses of Zinc in ALS PatientsCompletedPhase 1/2Phoenix Neurological Associates, LTDNCT01259050Written as Zinc and Copper
- Treatment With Copper in Patients With Mild Alzheimer´s DementiaCompletedPhase 2University Hospital, SaarlandNCT00608946Written as copper
Given in every arm · 1 — Copper is usual care beside what is tested
As the comparator · 2 — what is tested is compared with Copper
Codes
What other systems call Copper · ClinicalTrials.gg INT007262
- MeSH (NLM) D003300CopperConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 789U1901C5COPPERConfirmed FDA, NLM, Wikidata
- RxNorm 2837Confirmed FDA, Wikidata
- Wikidata Q753copperConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C391CopperOne source FDA
- DrugBank DB09130One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003300 | Copper | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 789U1901C5 | COPPER | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2837 | — | Confirmed FDA, Wikidata |
| Wikidata | Q753 | copper | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C391 | Copper | One source FDA |
| DrugBank | DB09130 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.